Full bibliography
Modelling the economic value of HealthPathways
Resource type
Authors/contributors
- Holland, Kieran (Author)
- La Salle, Ralph (Author)
- Gullery, Carolyn (Author)
- Al-Murani, Abbas (Author)
Title
Modelling the economic value of HealthPathways
Institution
Health Economics Consulting NZ
Place
Auckland
Date
September 2024
Language
en
Notes
Study topic:
Economic modelling of HealthPathways’ impact on health system costs and resource allocation, using international case studies and simulations.
Study type:
Independent economic modelling and cost-minimisation analysis.
Key findings:
- HealthPathways implementation across a hypothetical OECD country (population 5 million) yields an average net saving of NZ$442.9 million over five years.
- The model estimates a return on investment (ROI) of 876%, or NZ$9.76 for every NZ$1 invested.
- System-level impacts (e.g. reduced acute bed days and planned care referrals) drive most of the savings, with 99–100% of simulations showing cost reductions.
- Disease-specific impacts (e.g. diabetes, orthopaedics, COPD) show more variable savings, highlighting the importance of system-wide implementation.
- The model is conservative, excluding long-term and non-monetary benefits such as improved patient experience, clinician satisfaction, and system integration.
Citation
Holland, K., La Salle, R., Gullery, C., & Al-Murani, A. (2024). Modelling the economic value of HealthPathways. Health Economics Consulting NZ.
Topic
Link to this record